January 26, 2021
Horizons ETFs will begin offering investors exposure to the rising psychedelics market with the launch of a brand-new fund.
January 12, 2021
A growing list of the available psychedelics stocks to watch out for from the Investing News Network.
August 26, 2020
Revive to also explore FDA Expanded Access Program (Compassionate Use) for Bucillamine in COVID-19
May 13, 2020
Revive Therapeutics is pleased to provide a corporate update on its pharmaceutical programs for Bucillamine in the treatment of the...
April 29, 2020
Revive Therapeutics is pleased to provide further insight on its plans for its psilocybin-based pharmaceutical program.
April 23, 2020
Revive Therapeutics (CSE:RVV) has received positive feedback from the U.S. FDA in response to the company’s pre-IND meeting that was...
April 21, 2020
Revive Therapeutics (CSE:RVV) has entered into a SRPA with the University of Wisconsin-Madison to evaluate novel formulations and drug delivery...